BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.16B |
| 2 |
AbbVie
ABBV
|
+$1.93B |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$1.81B |
| 4 |
Otis Worldwide
OTIS
|
+$1.67B |
| 5 |
Carrier Global
CARR
|
+$1.43B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$3.74B |
| 2 |
RTN
Raytheon Company
RTN
|
+$2.93B |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$1.67B |
| 4 |
CY
Cypress Semiconductor
CY
|
+$779M |
| 5 |
iShares MBS ETF
MBB
|
+$772M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.92% |
| 2 | Healthcare | 14.84% |
| 3 | Financials | 12.13% |
| 4 | Consumer Discretionary | 10.93% |
| 5 | Communication Services | 8.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FAX
3351
abrdn Asia-Pacific Income Fund
FAX
$604M
| $7.2M | ﹤0.01% |
+314,885
| New | +$6.76M |
|
|
PARAA
3352
DELISTED
Paramount Global Class A
PARAA
| $7.17M | ﹤0.01% |
280,119
-79,556
| -22% | -$1.77M |
|
3353
EPR Properties 5.75% Series C Preferred Shares
EPR.PRC
$144M
| $7.17M | ﹤0.01% |
393,809
-22,814
| -5% | -$411K |
|
3354
Vanguard Morningstar Growth ETF
VUG
$228B
| $7.15M | ﹤0.01% |
212,316
-13,914
| -6% | -$428K |
|
|
ATXS
3355
DELISTED
Astria Therapeutics
ATXS
| $7.13M | ﹤0.01% |
184,686
+145,147
| +367% | +$5.17M |
|
3356
Ring Energy
REI
$357M
| $7.09M | ﹤0.01% |
6,109,026
-2,907,652
| -32% | -$2.84M |
|
3357
Savara
SVRA
$1.14B
| $7.07M | ﹤0.01% |
2,837,478
+538,355
| +23% | +$1.31M |
|
|
FLG.PRU
3358
Flagstar Bank National Association Bifurcated Option Note Unit Securities
FLG.PRU
$119M
| $7.07M | ﹤0.01% |
158,134
+18,272
| +13% | +$797K |
|
|
PZN
3359
DELISTED
Pzena Investment Management, Inc. Class A
PZN
| $7.06M | ﹤0.01% |
1,297,494
+117,406
| +10% | +$548K |
|
|
CVLY
3360
DELISTED
Codorus Valley Bancorp Inc
CVLY
| $7.01M | ﹤0.01% |
507,204
-1,010
| -0.2% | -$13.5K |
|
3361
Northeast Bank
NBN
$1.15B
| $6.99M | ﹤0.01% |
398,008
-34,010
| -8% | -$517K |
|
|
PAMT
3362
PAMT Corp
PAMT
$281M
| $6.98M | ﹤0.01% |
907,516
-19,520
| -2% | -$163K |
|
|
XIFR
3363
XPLR Infrastructure LP
XIFR
$1.08B
| $6.97M | ﹤0.01% |
135,842
+21,771
| +19% | +$1.05M |
|
3364
Cabaletta Bio
CABA
$455M
| $6.94M | ﹤0.01% |
622,683
+314,401
| +102% | +$2.41M |
|
3365
iShares MSCI Brazil ETF
EWZ
$8.6B
| $6.93M | ﹤0.01% |
241,141
+1,677
| +0.7% | +$44K |
|
3366
Aquestive Therapeutics
AQST
$553M
| $6.93M | ﹤0.01% |
1,425,806
+1,214,344
| +574% | +$5.59M |
|
3367
Mastech Digital
MHH
$94.5M
| $6.91M | ﹤0.01% |
266,385
+72,396
| +37% | +$1.28M |
|
|
AMTI
3368
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
| $6.89M | ﹤0.01% |
+274,147
| New | +$6.92M |
|
3369
Hercules Capital
HTGC
$3.12B
| $6.89M | ﹤0.01% |
657,692
+62,436
| +10% | +$634K |
|
|
AGS
3370
DELISTED
PlayAGS
AGS
| $6.88M | ﹤0.01% |
2,037,068
+151,430
| +8% | +$580K |
|
|
DESP
3371
DELISTED
Despegar.com
DESP
| $6.86M | ﹤0.01% |
955,397
-66,303
| -6% | -$461K |
|
|
DZSI
3372
DELISTED
DZS Inc. Common Stock
DZSI
| $6.86M | ﹤0.01% |
767,844
+222,514
| +41% | +$1.48M |
|
|
HOOK
3373
DELISTED
HOOKIPA Pharma
HOOK
| $6.85M | ﹤0.01% |
58,945
+12,726
| +28% | +$1.24M |
|
3374
iShares 0-5 Year Investment Grade Corporate Bond ETF
SLQD
$2.38B
| $6.82M | ﹤0.01% |
130,881
-160,212
| -55% | -$8.24M |
|
|
PFSW
3375
DELISTED
PFSweb, Inc.
PFSW
| $6.8M | ﹤0.01% |
1,018,784
+675,454
| +197% | +$3.58M |
|
Similar funds
BlackRock's Q2 2020 Portfolio in Review
As of Q2 2020, BlackRock held 5,263 positions worth $2.51T, up 23% from $2.04T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q2 2020 filing shows 247 new, 2,443 increased, 1,910 reduced and 215 closed positions. Its largest new stake was Otis Worldwide: 32,136,910 shares worth $1.83B. The largest sale was Allergan plc, an estimated $3.74B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2020 buy was Otis Worldwide: 32,136,910 shares worth $1.83B.
- BlackRock added most to Amazon in Q2 2020, an estimated $2.16B increase.
- BlackRock's biggest Q2 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $1.67B.
- BlackRock fully exited Allergan plc in Q2 2020, selling an estimated $3.74B.
- BlackRock's ten largest holdings make up 19% of its $2.51T portfolio in Q2 2020.
- BlackRock opened 247 new positions and closed 215 in Q2 2020.
- BlackRock's portfolio value rose 23% quarter-over-quarter to $2.51T.
Based on BlackRock's 13F filing for Q2 2020, filed 14 Aug 2020.